Garcia-Ropero et al. (10) proposed that SGLT-1 participates in pathological processes, such as glycolipid metabolism, oxidative stress, myocardial ischemia, and heart failure (HF). This evidence concerns the gene SLC5A1 and hydrops fetalis.